U.S. Medical Foods Market – Insights
Medical foods can be defined as specialized nutrient formulation to be consumed or administered enteral under the supervision of a healthcare practitioner. Medical foods are intended for the specific dietary management of a disease or a health condition. Moreover, majority of medical foods market is concentrated in the U.S. and Europe, owing to presence of key players in these regions such as Nestle Inc., Yakult Honsha Co., Ltd., and others.
Furthermore, growing awareness among individuals about medical foods, owing to the increasing health benefits of medical foods containing prebiotic and probiotics factors and increasing focus of market players on marketing of medical food product are expected to drive market growth over the forecast period. For instance in March 2018, Yakult Honsha Co., Ltd., is a probiotic manufacturing company conducted the ‘Yakult: Keep Drinking to Feel the Difference’ campaign, which contributed to higher sales of the company’s products in Japan.
The U.S. medical foods market size was valued at US$ 10,991.5 Mn in 2019, and is expected to exhibit a CAGR of 17.1% over the forecast period (2019-2027).
Increasing prevalence of gastrointestinal diseases is expected to propel market growth over the forecast period
Increasing demand for medical food due to individuals suffering from gastrointestinal diseases is expected to drive the U.S. medical foods market during the forecast period. For instance, according to the Centre for Disease Control and Prevention (CDC), 2017, clostridium difficile infection is one of the most common healthcare-associated infections in the U.S. that affects over 500,000 people, and results around 15,000 deaths annually.
Furthermore, increasing incidence and prevalence of Crohn’s disease in the U.S. is expected to drive the market growth over the forecast period. For instance, according to the Centers for Disease Control and Prevention’s 2018 statistics, an estimated 3 million adults in the U.S. were diagnosed with an inflammatory bowel disease (Crohn’s disease or ulcerative colitis) in 2015. This was a significant increase from the estimates in 1999, which accounted for 0.9% of the U.S. population, or 2 million adults.
However, stringent regulations for product approval are expected to hinder growth of the U.S. medical foods market during the forecast period. For instance, according to the U.S. FDA guidelines published in 2016, probiotics cannot be marketed to cure, treat, and prevent any diseases. Moreover, according to the guidelines, probiotic products proposed for investigational use need to be lawfully marketed as conventional food or dietary supplement.
Figure 1. U.S. Medical Foods Market Share (%), by Food Type, 2027
Source: Coherent Market Insights Analysis (2019)
Increasing awareness regarding prebiotics and probiotic products is anticipated to propel the market growth over the forecast period
Medical food with prebiotics and probiotics is expected to gain significant traction among consumers in U.S. due to health benefits associated with it. Probiotics offers beneficial microbiome for the body, which are essential for improving metabolic process. Increasing popularity of prebiotic and probiotic based food is evident from rising sales of these products globally. For instance, Yakult Honsha Co. Ltd., a supplier and manufacturer of probiotic drinks, sold 373 thousands bottle of probiotic drinks per day in the U.S. during January 2019 to June 2019. Moreover, Yakult Honsha Co. Ltd., is also focusing on expanding the consumer base for its low calorie products. For instance, in August 2019, the company expanded sales of Yakult Light, a probiotic drink in 15 states in the eastern U.S. to increase awareness of its products among health conscious consumers.
Furthermore, key players in the market are focusing on geographic expansion, in order to increase their market presence in the developed market. For instance in July 2019, DuPont, a U.S.-based chemical company inaugurated its new fermentation unit at its facility in New York, U.S., in order to expand its production of probiotics, and offer health and nutrition products in New York market.
Major players operating in the U.S. medical foods market include Enterome SA, Yakult Honsha Co., Ltd., Abbott, ExeGi Pharma, LLC, VSL Pharmaceuticals, Inc., Entera Health, Inc., Meiji Holdings Co., Ltd., Danone, and Nestlé S.A.